Skip to main content

Advertisement

SpringerLink
Log in

An association between fibrinogen gene polymorphisms and diabetic peripheral neuropathy in young patients with type 1 diabetes

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

In complex etiopathogenesis of diabetic peripheral neuropathy (DPN), hemostatic dysfunction and subclinical inflammation play a possible role. Fibrinogen is involved in both the hemostatic and inflammatory pathways, so we hypothesize that fibrinogen gene polymorphisms might be associated with DPN. A total of 127 young patients with type 1 diabetes (T1D) (average age, 18.5 ± 4.65 years; average diabetes duration, 14.5 ± 2.26 years) and 90 healthy controls were enrolled into the study. Basic biochemical and coagulation parameters were measured and gene polymorphisms of fibrinogen alpha (rs6050) and beta (rs1800790) were established. DPN was diagnosed in 38 diabetic patients by neurological examination. AA genotype and A allele of rs1800790 polymorphism of fibrinogen beta were associated with increased risk of DPN (odds ratio [OR] 4.537, 95% confidence interval [95CI] 1.14–19.94, p = 0.019 and OR 1.958, 95CI 1.038–3.675, p = 0.029, respectively). No association was found between DPN and rs6050 gene polymorphisms. Plasma fibrinogen concentration significantly correlated with HbA1c (Spearman‘s correlation coefficient [r] = 0.54) and HDL cholesterol (r = − 0.67). A allele and AA genotype of rs1800790 seem to be associated with DPN in young patients with T1D. Further studies are appropriate to elucidate the role of fibrinogen gene polymorphisms in the complex etiology of DPN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Data availability

The datasets generated and analyzed during the study are available from corresponding author on reasonable request.

References

  1. Domingueti CP, Fuzatto JA, Fóscolo RB et al (2016) Association between Von Willebrand factor, disintegrin and metalloproteinase with thrombospondin type 1 motif member 13, d-dimer and cystatin C levels with retinopathy in type 1 diabetes mellitus. Clin Chim Acta 459:1–4

    Article  CAS  Google Scholar 

  2. Brndiarova M, Antonyova M, Dedinska I, Havlicekova Z, Jesenak M (2020) Nephronophtisis type I, left ventricular non-compaction cardiomyopathy and reduced cilia motility—atypical manifestations of one disease. J Nephrol 33:183–186

    Article  Google Scholar 

  3. Dahlin LB, Elgzyri T, Löndahl M, Ekman L, Lindholm E (2020) Improved metabolic control using glucose monitoring systems leads to improvement in vibration perception thresholds in type 1 diabetes patients. Acta Diabetol 57:433–438

    Article  CAS  Google Scholar 

  4. Pop-Busui R, Ang L, Holmes C, Gallagher K, Feldman EL (2016) Inflammation as a therapeutic target for diabetic neuropathies. Curr Diabetes Rep 16:29

    Article  Google Scholar 

  5. Picconi F, Parravano M, Ylli D, Pasqualetti P, Coluzzi S, Giordani I, Malandrucco I, Lauro D, Scarinci F, Giorno P, Varano M, Frontoni S (2017) Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability. Acta Diabetol 54:489–497

    Article  CAS  Google Scholar 

  6. Jesenak M, Babusikova E, Evinova A, Banovcin P, Dobrota D (2015) Val66Met polymorphism in the BDNF gene in children with bronchial asthma. Pediatr Pulmonol 50:631–637

    Article  Google Scholar 

  7. Dedinská I, Palkoci B, Miklušica J, Osinová D, Galajda P, Mokáň M (2017) Metabolic syndrome and new onset diabetes after kidney transplantation. Diabetes Metab Syndr 11:211–214

    Article  Google Scholar 

  8. Shavit-Stein E, Aronovich R, Sylantiev C, Gofrit SG, Chapman J, Dori A (2019) The role of thrombin in the pathogenesis of diabetic neuropathy. PLoS ONE 14:e0219453

    Article  CAS  Google Scholar 

  9. Samuelsson K, Press R (2018) Microangiopathy—a potential contributing factor to idiopathic polyneuropathy: a mini review. Front Neurol 9:43

    Article  Google Scholar 

  10. Arbustini E, Narula N, D’Armini AM (2013) Fibrinogen, a circulating factor in search of its genetic architecture. Circulation 128:1276–1280

    Article  Google Scholar 

  11. van’t Hooft FM, von Bahr SJ, Silveira A, Iliadou A, Eriksson P, Hamsten A (1999) Two common, functional polymorphisms in the promoter region of the beta-fibrinogen gene contribute to regulation of plasma fibrinogen concentration. Arterioscler Thromb Vasc Biol 19:3063–3070

    Article  Google Scholar 

  12. Luo H, Li X, Jiang A, Zhang B, Bi P, Dong Y, Guo Y (2019) Associations of β-fibrinogen polymorphisms with the risk of ischemic stroke: a meta-analysis. J Stroke Cerebrovasc Dis 28:243–250

    Article  Google Scholar 

  13. Arvidson NG, Larsson A, Lasren A (2009) Disease activity in rheumatoid arthritis: fibrinogen is superior to the erythrocyte sedimentation rate. Scand J Clin Lab Investig 62:315–319

    Article  Google Scholar 

  14. Yazici A, Senturk O, Aygun C, Celebi A, Caglayan C, Hulagu S (2010) Thrombophilic risk factors in patients with inflammatory bowel disease. Gastroenterol Res 3:112–119

    CAS  Google Scholar 

  15. Miranda Acuña J, Hidalgo de la Cruz M, Ros AL, Tapia SP, MartínezGinés ML, de Andrés Frutos CD (2017) Elevated plasma fibrinogen levels in multiple sclerosis patients during relapse. Mult Scler Relat Disord 18:157–160

    Article  Google Scholar 

  16. Bembde AS (2012) A study of plasma fibrinogen level in type-2 diabetes mellitus and its relation to glycemic control. Indian J Hematol Blood Transfus 28:105–108

    Article  Google Scholar 

  17. Zhang J, Wang Y, Zhang R, Li H, Han Q, Wu Y, Wang S, Guo R, Wang T, Li L, Liu F (2018) Serum fibrinogen predicts diabetic ESRD in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 141:1–9

    Article  CAS  Google Scholar 

  18. Yu X, Hu F, Yao Q, Li C, Zhang H, Xue Y (2016) Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer 16:480

    Article  Google Scholar 

  19. Zhang X, Long Q (2017) Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients. Medicine (Baltimore) 96:e6694

    Article  CAS  Google Scholar 

  20. Petersen MA, Ryu JK, Akassoglou K (2018) Fibrinogen in neurological diseases: mechanisms, imaging and therapeutics. Nat Rev Neurosci 19:283–301

    Article  CAS  Google Scholar 

  21. Li JF, Lin Y, Yang YH et al (2013) Fibrinogen Aα Thr312Ala polymorphism specifically contributes to chronic thromboembolic pulmonary hypertension by increasing fibrin resistance. PLoS ONE 8:e69635

    Article  CAS  Google Scholar 

  22. Zhang J, Yu L, Yin Y et al (2013) Association between two functional fibrinogen-related polymorphisms and ischemic stroke: a case-control study. Genet Test Mol Biomark 17:789–793

    Article  CAS  Google Scholar 

  23. Rasmussen-Torvik LJ, Cushman M, Tsai MY et al (2007) The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study. Thromb Res 121:1–7

    Article  CAS  Google Scholar 

  24. Oszajca K, Wroński K, Janiszewska G et al (2012) Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen β chain genes with human abdominal aortic aneurysm. Exp Ther Med 4:514–518

    Article  CAS  Google Scholar 

  25. Hu X, Wang J, Li Y et al (2017) The β-fibrinogen gene 455G/A polymorphism associated with cardioembolic stroke in atrial fibrillation with low CHA2DS2-VaSc score. Sci Rep 7:17517

    Article  Google Scholar 

  26. Mayer-Davis EJ, Kahkoska AR, Jefferies C et al (2018) ISPAD clinical practice consensus guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes 19:S7-19

    Article  Google Scholar 

  27. Herman WH, Pop-Busui R, Braffett BH et al (2012) Use of the michigan neuropathy screening instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the diabetes control and complications trial/epidemiology of diabetes interventions and complications. Diabet Med 29:937–944

    Article  CAS  Google Scholar 

  28. Lewis CM (2002) Genetic association studies: design, analysis and interpretation. Brief Bioinform 3:146–153

    Article  CAS  Google Scholar 

  29. Brownlee M (2005) The pathobiology of diabetic complications. A unifying mechanism. Diabetes 54:1615–1625

    Article  CAS  Google Scholar 

  30. Kallinikou D, Soldatou A, Tsentidis C, Louraki M, Kanaka-Gantenbein C, Kanavakis E, Karavanaki K (2019) Diabetic neuropathy in children and adolescents with type 1 diabetes mellitus: diagnosis, pathogenesis, and associated genetic markers. Diabetes Metab Res Rev 35:e3178

    Article  Google Scholar 

  31. Siegerink B, Rosendaal FR, Algra A (2009) Genetic variation in fibronogen; its relationship to fibrinogen levels and the risk of myocardial infarcion and ischemic stroke. J Thromb Haemost 7:385–390

    Article  CAS  Google Scholar 

  32. Jacquemin B, Antoniades C, Nyberg F, Plana E, Muller M, Greven S, Salomaa V, Sunyer J, Bellander T, Chalamandaris AG, Pistelli R, Koenig W, Peters A (2008) Common genetic polymorphisms and haplotypes of fibrinogen alpha, beta and gamma chains affect fibrinogen levels and the response to proinflammatory stimulation in myocardial infarction survivors. J Am Coll Cardiol 52:941–952

    Article  CAS  Google Scholar 

  33. Canseco-Avila LM, Lopez-Roblero A, Serrano-Guzman E, Aguilar-Fuentes J, Jerjes-Sanchez C, Rojas-Martinez A, Ortiz-Lopez R (2019) Polymorphisms -455G/A and -148C/T and fibrinogen plasmatic level as risk markers of coronary disease and major adverse cardiovascular events. Dis Markers 2019:5769514. https://doi.org/10.1155/2019/5769514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Klein RL, Hunter SJ, Jenkins AJ, Zheng D, Semler AJ, Clore J, Garvey T, The DCCT/EDIC Study Group (2003) Fibrinogen is a marker for nephropathy and peripheral vascular disease in type 1 diabetes. Diabetes Care 26:1439–1448

    Article  CAS  Google Scholar 

  35. Tybjaerg-Hansen A, Agerholm-Larsen B, Humphries SE, Abildgaard S, Schnohr P, Nordestgaard BG (1997) A common mutation (G-455–> A) in the beta-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischemic heart disease. A study of 9,127 individuals based on the Copenhagen City Heart Study. J Clin Investig 99:3034–3039

    Article  CAS  Google Scholar 

  36. Rudnicka AR, Rumley A, Lowe GD, Strachan DP (2007) Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 115:996–1003

    Article  CAS  Google Scholar 

  37. Nyaga DM, Vickers MH, Jefferies C, Perry JK, O’Sullivan JM (2018) The genetic architecture of type 1 diabetes mellitus. Mol Cell Endocrinol 477:70–80

    Article  CAS  Google Scholar 

  38. Vojtková J, Durdik P, Ciljakova M, Michnova Z, Turcan T, Babusikova E (2013) The association between gene polymorphisms of glutathione S-transferase T1/M1 and type 1 diabetes in Slovak children and adolescents. Cent Eur J Public Health 21:88–91

    Article  Google Scholar 

  39. Walter-Höliner I, Barbarini DS, Lütschg J, Blassnig-Ezeh A, Zanier U, Saely CH, Simma B (2018) High prevalence and incidence of diabetic peripheral neuropathy in children and adolescents with type 1 diabetes mellitus: results from a five-year prospective cohort study. Pediatr Neurol 80:51–60

    Article  Google Scholar 

  40. Amer ME, Kamal HM, Siam AG (2019) Study of peripheral neuropathy in children with type 1 diabetes mellitus at Zagazig University Hospitals. Zagazig Univ Med J 25:116–125

    Article  Google Scholar 

Download references

Funding

This study was funded by Grant VEGA 1/0310/18.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Jessenius Faculty of Medicine and University Hospital, Comenius University in Bratislava, Kollárova 2, 036 01, Martin, Slovakia

    Jarmila Vojtková, Zuzana Kolková, Katarína Motyková, Martina Kostková, Stanislava Suroviaková & Peter Bánovčin

  2. Jessenius Faculty of Medicine, Biomedical Center Martin, Comenius University in Bratislava, Martin, Slovakia

    Zuzana Kolková

  3. Jessenius Faculty of Medicine, Bioinformatic Center, Biomedical Center Martin, Comenius University in Bratislava, Martin, Slovakia

    Marián Grendár

Authors
  1. Jarmila Vojtková
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zuzana Kolková
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katarína Motyková
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Martina Kostková
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Stanislava Suroviaková
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marián Grendár
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Peter Bánovčin
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept and design were contributed by JV, ZK, KM, MK, SS and PB; acquisition of data was contributed by KM and MK; statistical analysis was contributed by MG; analysis and data interpretation were contributed by JV, ZK and PB; drafting of manuscript was contributed by JV and SS; critical revision was contributed by ZK and PB. All authors approved the final version of the article, including the authorship list.

Corresponding author

Correspondence to Stanislava Suroviaková.

Ethics declarations

Conflict of interest

The authors have no conflict of interest.

Ethical approval

The study has been reviewed by the ethics committee and have been performed in accordance with the ethical standards laid down in an appropriate version of the 1964 Declaration of Helsinki.

Consent to participate

All adult persons (or in children, their legal representatives) gave their informed consent to participate prior to their inclusion in the study.

Consent for publication

All adult persons (or in children, their legal representatives) gave their informed consent for publication of the results in the scientific journal.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vojtková, J., Kolková, Z., Motyková, K. et al. An association between fibrinogen gene polymorphisms and diabetic peripheral neuropathy in young patients with type 1 diabetes. Mol Biol Rep 48, 4397–4404 (2021). https://doi.org/10.1007/s11033-021-06455-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-021-06455-1

Keywords

Search

Navigation